Insights

Gathering insights about Salus…

Similar companies to Salus

Salus Tech Stack

Salus uses 8 technology products and services including LiteSpeed Cache, Webpack, jQuery Migrate, and more. Explore Salus's tech stack below.

LiteSpeed Cache
Caching
Webpack
Development
jQuery Migrate
Javascript Libraries
jQuery
Javascript Libraries
Priority Hints
Performance
PHP
Programming Languages
Yoast SEO
Search Engines
Google Analytics
Web Analytics

Media & News

TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model”
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), TriSalus Life Sciences, which seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and our investigational immunotherapy, announced today that company researchers received two JVIR Top Paper Awards for a recent publication, including the JVIR Editor's Award for Distinguished Laboratory Investigation and the J.
Mar 06, 2025 | www.businesswire.com
TriSalus Life Sciences Announces Key Appointments to Board of Directors
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), a biomedical technology company seeking to transform outcomes for patients with solid tumors by integrating its innovative delivery technology with standard-of-care therapies and its investigational immunotherapy, today announced the appointment of two distinguished HealthCare Industry veterans to its Board of Directors. Mr. William J. Valle and Gary B. Gordon, M.D., Ph.D., joined the Company's Board of Directors, effective a.
Feb 03, 2025 | www.businesswire.com
TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), a biomedical technology company seeking to transform outcomes for patients with solid tumors by integrating its innovative delivery technology with standard-of-care therapies and its investigational immunotherapy, today announced that it has requested a drawdown of $10 million under its previously announced $50 million credit agreement with OrbiMed, a healthcare investment firm. Pursuant to the to the Agreement, OrbiMed agree.
Feb 03, 2025 | www.businesswire.com
TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), is announcing preliminary unaudited fourth quarter and full year 2024 financial results and details of the upcoming conference call. Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results Full financial results for the year ended December 31, 2024 are in the process of being finalized, however initial and preliminary results show revenue, driven solely by the TriNav® Infusion System, of approximately $8.3 m.
Jan 23, 2025 | www.businesswire.com
TriSalus Life Sciences: Continuing To Maintain Optimism As Costs Are Cut
TriSalus Life Sciences continues to develop its TriNav infusion system, expanding its reach in liver and pancreatic cancer treatment, despite shifting focus from drug development. TLSI's financials show a $2.4 million net loss for the quarter, but management is optimistic about turning cash flow positive by 2025. The company faces risks with low cash reserves and potential need for dilutive fundraising, despite cost reduction efforts and growing product sales.
Dec 24, 2024 | seekingalpha.com
TriSalus Life Sciences, Inc. (TLSI) Q3 2024 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ:TLSI ) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Company Participants Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & Chief Executive Officer Sean Murphy - Chief Financial Officer Conference Call Participants Jason Wittes - ROTH Suraj Kalia - Oppenheimer & Company William Plovanic - Canaccord Genuity Justin Walsh - JonesTrading Operator Good morning, and welcome to TriSalus Science's Third Quarter 2024 Earnings Conference Call. Currently, all participants are in a listen-only mode.
Nov 14, 2024 | seekingalpha.com
TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company dedicated to enhancing outcomes for patients suffering from liver cancer through its advanced delivery technology as well as an investigational immunotherapy, nelitolimod, has announced a strategic partnership with Geo-Med, LLC (“Geo-Med”), a certified Service-Disabled Veteran-Owned Small Business (SDVOSB), to expand availability of the TriNav Infusion System (“TriNav”) to U.S.
Nov 11, 2024 | www.businesswire.com

Salus's Email Address Formats

Salus uses at least 1 format(s):

Salus Email Formats	Example	Percentage
First.Last@salusservices.co.uk	John.Doe@salusservices.co.uk	46%
FLast@salusservices.co.uk	JDoe@salusservices.co.uk	4%
First.Last@salusservices.co.uk	John.Doe@salusservices.co.uk	46%
FLast@salusservices.co.uk	JDoe@salusservices.co.uk	4%

Frequently Asked Questions

What is Salus's stock symbol?

Salus is a publicly traded company; the company's stock symbol is TLSI.

What is Salus's official website and social media links?

Salus's official website is salusservices.co.uk and has social profiles on LinkedIn.

What is Salus's NAICS code?

Salus's NAICS code is 5416 - Management, Scientific, and Technical Consulting Services.

How many employees does Salus have currently?

As of March 2025, Salus has approximately 120 employees across 6 continents, including EuropeNorth AmericaSouth America. Key team members include Founder & Ceo: J. B. K.President: D. S.Owner: G. O.. Explore Salus's employee directory with LeadIQ.

What industry does Salus belong to?

Salus operates in the Business Consulting and Services industry.

What technology does Salus use?

Salus's tech stack includes LiteSpeed CacheWebpackjQuery MigratejQueryPriority HintsPHPYoast SEOGoogle Analytics.

What is Salus's email format?

Salus's email format typically follows the pattern of . Find more Salus email formats with LeadIQ.

Salus

Business Consulting and Services51-200 Employees

Learn about working at Salus. Join LinkedIn today for free. See who you know at Salus, leverage your professional network, and get hired.

Company Overview

Website: salusservices.co.uk
Stock Symbol: TLSI
NAICS Code: 5416 - Management, Scientific, and Technical Consulting Services
Employees: 51-200